Aeterna Zentaris
AEZS
#10566
Rank
โ‚ฌ15.32 M
Marketcap
5,00ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -1,90ย โ‚ฌ

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -1,79ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,10ย โ‚ฌ a decrease over its 2021 EPS that were of -1,59ย โ‚ฌ.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-1,90ย โ‚ฌ
2022-4,10ย โ‚ฌ157.14%
2021-1,59ย โ‚ฌ-41.48%
2020-2,72ย โ‚ฌ-64.46%
2019-7,66ย โ‚ฌ-240%
20185,47ย โ‚ฌ-122.32%
2017-24,50ย โ‚ฌ-53.53%
2016-52,72ย โ‚ฌ-86.71%
2015-396,81ย โ‚ฌ-35.21%
2014-612,50ย โ‚ฌ-216.67%
2013525,00ย โ‚ฌ-123.3%
2012-2.253ย โ‚ฌ-40.8%
2011-3.806ย โ‚ฌ-6.45%
2010-4.069ย โ‚ฌ-27.91%
2009-5.644ย โ‚ฌ-61.61%
2008-14.700ย โ‚ฌ83.61%
2007-8.006ย โ‚ฌ-195.31%
20068.400ย โ‚ฌ178.26%
20053.019ย โ‚ฌ-330%
2004-1.312ย โ‚ฌ-80.05%
2003-6.579ย โ‚ฌ17.78%
2002-5.586ย โ‚ฌ515.93%
2001-906,89ย โ‚ฌ-68.6%
2000-2.888ย โ‚ฌ128.04%
1999-1.267ย โ‚ฌ-3.63%
1998-1.314ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
6,14ย โ‚ฌ-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
2,24ย โ‚ฌ-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
3,12ย โ‚ฌ-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,32ย โ‚ฌ-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
2,28ย โ‚ฌ-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA